sglt2 inhibition for the prevention and treatment of kidney disease in patients with type 2 diabetes
Published 5 years ago • 12K plays • Length 40:23Download video MP4
Download video MP3
Similar videos
-
19:55
improving renal outcomes with glucose-lowering therapy in the individualized management of t2dm
-
9:06
sglt2 inhibitors in chronic kidney disease
-
46:01
ckd e-learning - sglt-2 inhibitors and ckd - 05.19.21
-
31:52
managing heart failure: are sglt2 inhibitors the next leap forward in optimizing patient care?
-
13:49
using sglt2-inhibitors to treat cardiac patients with diabetes
-
9:55
how sglt2 inhibitors protect the kidney in patients with diabetes mellitus?
-
3:23
what are sglt2 inhibitors - chronic kidney disease | uhl nhs trust
-
5:08
nephroworldcup 2022: metformin or sglt2i in ckd patients with diabetes
-
58:38
nephrology grand rounds: sglt2 inhibitors
-
16:24
how sglt2 inhibitors protect the kidney
-
6:58
sglt2 inhibitors in t1d: 'people are using them now'
-
35:24
professor david wheeler - 'how do sglt2 inhibitors benefit the kidney?'
-
0:30
sglt2 inhibitors for diabetics
-
13:40
e139 – sglt2 inhibitors for kidney and heart disease
-
30:05
professor david wheeler - renoprotective effects of sglt2 inhibitors
-
32:47
embracing the guidelines to appropriately individualize care for patients with type 2 diabetes
-
49:14
sglt2 inhibitors: can these drugs slow the progression of chronic kidney disease?
-
32:00
role of sglt2 inhibitors in ckd
-
27:44
are there alternative mechanisms to explain sglt2i beneficial cveffects in some patients?